Acute coronary syndrome emergency treatment strategies: Improved treatment and reduced mortality in patients with acute coronary syndrome using guideline-based critical care pathways

American Heart Journal

Volumn 157, Issue 1, 2009, Pages 61-68

  Corbelli, John C ^a   Janicke, David M ^b   Cziraky, Mark J ^c   Hoy, Tracey A ^c   Corbelli, Jennifer A ^d,e  

^a UNIVERSITY AT BUFFALO   (United States)

^b PLLC   (United States)

^c HEALTHCORE INC   (United States)

^d Buffalo Cardiology and Pulmonary Associates   (United States)

^e UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL PATHWAY; COHORT ANALYSIS; CONTROLLED STUDY; EMERGENCY TREATMENT; FEMALE; HEALTH INSURANCE; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; CRITICAL PATHWAYS; EMERGENCY TREATMENT; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PRACTICE GUIDELINES AS TOPIC;

EID: 57249095770     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.08.022     Document Type: Article

References (13)

1. Califf R.M., Peterson, Gibbons R.J., et al. Integrating quality into the cycle of therapeutic development. J Am Coll Cardiol 40 (2002) 1895-1901
2. Peterson E.D., Roe M.T., Mulgund J., et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 295 (2006) 1912-1920
3. Werner R.M., and Bradlow E.T. Relationship between Medicare's hospital compare performance measures and mortality rates. JAMA 296 (2006) 2694-2702
4. Cannon C.P. Critical pathway for unstable angina and non-ST elevation myocardial infarction. Crit Pathways Cardiol 1 (2002) 12-21
5. Cannon C.P., Bahit M.C., Haugland J.M., et al. Underutilization of evidence-based medications in acute ST elevation myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 9 registry. Crit Pathways Cardiol 1 (2002) 44-52
6. Fonarow G.C., Gawinski A., Moughrabi S., et al. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 85 (2000) 10A-17A
7. Eagle K.A., Montoye C.K., Riba A.L., et al. Guideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute myocardial infarction. J Am Coll Cardiol 46 (2005) 1242-1248
8. Corbelli J.C., Janicke D.M., Corbelli J.A., et al. Acute coronary syndrome emergency treatment strategies: a rationale and road map for critical pathway implementation. Crit Pathways Cardiol 2 (2003) 71-87
9. Braunwald E., Antman E.M., Beasley J.W., et al. 2002: ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction. J Am Coll Cardiol 40 (2002) 1366-1374
10. Ryan T.J., Antman E.M., Brooks, et al. 1999 update: ACC/AHA guidelines for the management of patients with myocardial infarction. Circulation 110 (2004) 588-636
11. Lin D.Y., and Wei L.J. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 84 (1989) 1074-1078
12. Rasmussen J.N., Chong A., and Alter D.A. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 297 (2007) 177-186
13. Ho P.M., Spertus J.A., Masoudi F.A., et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Int Med 166 (2006) 1842-1847